Thus protection conferred by maraviroc gel against HIV-1 vaginal challenge is highly significant (p value 0.0006, Fisher's exact test).
← all excerpts
A topical microbicide gel formulation of CCR5 antagonist maraviroc prevents HIV-1 vaginal transmission in humanized RAG-hu mice.
1
—
—